NEULAND LAB LTD. Valuation
NEULANDLAB · Healthcare · Current price ₹18,434
Is NEULAND LAB LTD. undervalued?
DocStoX estimates the fair value of NEULAND LAB LTD. at ₹4,840 per share, versus the current market price of ₹18,434. That puts the stock about -73.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹2,208), Relative P/E (₹11,096), Graham floor (₹3,054). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹2,208 (bear) to ₹4,840 (base) to ₹11,096 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
NEULAND LAB LTD. trades at a P/E of 65.0x and a P/B of 13.4x, with a dividend yield of 0.2%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on NEULAND LAB LTD.
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.